Meloxicam/Rizatriptan Combo Under Review for Migraine Treatment
The application is supported by data from the phase 3 MOMENTUM and INTERCEPT trials.
Migraine
Trudhesa Nasal Spray Approved for Acute Treatment of Migraine
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
Study Compares Remote Electrical Neuromodulation to Migraine Meds in Adolescents
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.
Complex Interaction Between Migraine Symptoms and Gastrointestinal Comorbidities
Researchers searched publication databases for studies of the gut-brain connection, migraine, and gastric disorders.
Nurtec ODT Approval Expanded to Include Migraine Prevention
Rimegepant is an oral calcitonin gene-related peptide receptor antagonist.
Atorvastatin With Sodium Valproate Can Reduce Migraine Attacks and Pain Severity
Atorvastatin may have augmentative effects with sodium valproate in the reduction of migraines with aura.
Comparing Mindfulness Meditation With Headache Education for Migraine
Researchers presented their study results comparing headache education with mindfulness-based stress reduction for patients with migraine at the AAN 2021 Virtual Annual Meeting,
Experts Weigh in on Evaluating, Treating Comorbid Migraine and Temporomandibular Dysfunction
Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.
Can Functional MRI Aid in the Diagnosis of Migraine?
Distinct pattern of abnormal brain connection on fMRI can assist in the differentiation between a healthy brain and a brain with migraine without aura.
Ubrogepant Works Quickly to Relieve Acute Migraine Pain
Ubrogepant, the newly approved calcitonin gene-related peptide antagonist, can relieve migraine symptoms within 2 hours after initial dose.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...